Stockwinners Market Radar for November 09, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:10 EDT SJW Corp. to acquire Deer Creek Ranch water system assets - SJW Group announced that SJWTX, doing business as Canyon Lake Water Service Company, a wholly-owned subsidiary of SJW Group, entered into an agreement to purchase Deer Creek Ranch Water Co., LLC's water system assets. The system includes approximately 750 service connections over an area of 1,191 acres in Hays and Travis counties on the rapidly growing western fringe of the Austin metropolitan area and is located about 40 miles north of SJWTX, Inc.'s existing water system in Comal County. The agreement is subject to customary closing conditions, including the approval by the Public Utility Commission of Texas.

18:38 EDT Emerson COO Ed Purvis to retire from the company - Emerson announced the retirement of COO Ed Purvis after 34 years with the company. His retirement is effective December 31. Steve Pelch, currently executive VP of organization planning and development, will succeed Purvis as executive VP and COO of the company, effective January 1, 2018. Purvis, who began his career with Emerson in 1983 as a product planner with Copeland Corporation, quickly took on numerous roles of increasing responsibility. Prior to being named COO in 2015, he served nearly seven years as executive VP and business leader of Emerson Climate Technologies, now Emerson Commercial and Residential Solutions.

18:30 EDT General Electric awarded $643M government contract - General Electric, Cincinnati, Ohio, has been awarded a $643M indefinite-delivery/indefinite-quantity undefinitized contract action to provide F110-GE-129 install engines, spare engines, modernized engine monitoring system computers, over-and-above repair for government furnished property, and technical data reports. Work will be performed in Cincinnati, Ohio, with an expected completion date of Nov. 8, 2024. This contract involves 100 percent foreign military sales to Qatar, Saudi Arabia and Bahrain. Air Force Life Cycle Management Center, Wright-Patterson Air Force Base, Ohio, is the contracting activity.

18:05 EDT MediciNova to evaluate mN-166 in methamphetamine use disorder with partners - MediciNova plans to initiate a biomarker study for evaluating MN-166 in methamphetamine use disorder, in collaboration with the U.S. Department of Veterans Affairs and Oregon Health & Science University. The proposed clinical trial will evaluate MN-166 (ibudilast) as a potential treatment for individuals diagnosed with MA use disorder with or without post-traumatic stress disorder. This study has already completed FDA review. The study endpoints are to determine the relationship between positron emission tomography/magnetic resonance spectroscopy markers of neuroinflammation and ventral striatal responses to reward; to determine whether a 4-week treatment of ibudilast reduces neuroinflammation and alters brain function compared to placebo; and, to determine if changes in neuroinflammation track with changes in mesocorticolimbic RSFC and in ventral striatal responses to reward.

17:53 EDT Bruker discloses subpoena, probe notice from SEC enforcement division - In a regulatory filing, Bruker said that on October 19, 2017, it received a notice of investigation and subpoena to produce documents from the Division of Enforcement of the SEC. The subpoena seeks information related to an employee terminated as part of a restructuring and certain matters involving the company's policies and accounting practices related to revenue recognition and restructuring activities, as well as related financial reporting, disclosure and compliance matters, since January 1, 2013. The subpoena also seeks information concerning, among other things, the company's previously identified material weakness in internal controls over the accounting for income taxes, related financial reporting matters and certain payments for non-employee travel expenses. The company intends to cooperate fully with the SEC's investigation. The company noted that, at this time, it is unable to predict the duration, scope or outcome of this investigation.

17:41 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: BioLife Solutions (BLFS), up 17.5%... voxeljet (VJET), up 14.3%... Omeros (OMER), up 13.5%... Kindred Biosciences (KIN), up 13.3%... Hertz (HTZ), up 8.7%... Immunomedics (IMMU), up 8.5%... Dillard's (DDS), up 4.2%... Nvidia (NVDA), up 1.9%... Disney (DIS), up 1.6%. ALSO HIGHER: Dynavax (DVAX), up 15.4% after it announced FDA approval of HEPLISAV-B... Western Digital (WDC), up 1.6% after it was authorized to resume potential share repurchases. DOWN AFTER EARNINGS: Puma Biotechnology (PBYI), down 12%... Trade Desk (TTD), down 11.4%... Redfin (RDFN), down 6.9%... Ichor Holdings (ICHR), down 5.1%... Intrexon (XON), down 3.2%.

17:18 EDT Nvidia raises quarterly dividend 7% to 15c per share - For fiscal 2019, NVIDIA intends to return $1.25B to shareholders through ongoing quarterly cash dividends and share repurchases. The company announced a 7% increase in its quarterly cash dividend to 15c per share from 14c per share, to be paid with its next quarterly cash dividend on December 15 to all shareholders of record on November 24.

17:12 EDT Nvidia says seeing robust growth in HPC business

17:10 EDT Nvidia says saw robust demand across all form factors - Says remains nimble in approach to cryptocurrency market. Comments from Q3 earnings conference call.

17:04 EDT Third Point raises Alibaba stake, lowers Alphabet stake, exits General Dynamics - Third Point disclosed in an SEC filing its holdings as of September 30. Third Point's ten new buys during the third quarter included, by size of position, Vantiv (VNTV), Shire (SHPG), Marathon Petroleum (MPC), Dover (DOV), and Macerich (MAC). Third Point exited five positions during the quarter, including by size of previous position, General Dynamics (GD), Humana (HUM), Charter Communications (CHTR), Hewlett Packard Enterprise (HPE), and EQT Corp (EQT). Third Point increased its stake in six holdings, including by size of previous position, Alibaba (BABA), Vulcan Materials (VMC), FMC Corp (FMC), and RSP Permian (RSPP). Third Point reduced its stake in ten holdings, including by size of previous position, Alphabet (GOOGL), Time Warner (TWX), T-Mobile US (TMUS), and Bank of America (BAC). Third Point's top holdings as of September 30, in order of size, were Baxter (BAX), Alibaba, DowDuPont (DWDP), BlackRock (BLK), and Facebook (FB).

17:04 EDT Electronic Arts to acquire Respawn Entertainment for $151M in cash - Electronic Arts announced an agreement to acquire Respawn Entertainment, a leading independent game development studio and creators of AAA shooter and action games including the critically-acclaimed Titanfall franchise. Respawn will join EA's Worldwide Studios organization, a global creative collective of leading game development studios bringing to life an unmatched portfolio of top games and services across all major platforms. Under the agreement, EA will pay $151M in cash, and up to $164M in long-term equity in the form of restricted stock units to employees, which will vest over four years. In addition, EA may be required to pay additional variable cash consideration that is contingent upon achievement of certain performance milestones, relating to the development of future titles, through the end of calendar 2022. The additional consideration is limited to a maximum of $140M. The transaction is expected to close by the end of the calendar 2017 or soon thereafter, subject to regulatory approvals and other customary closing conditions. The acquisition is expected to be neutral to EA's net income in fiscal years 2018 and 2019.

16:54 EDT Disney says not taking any questions on press speculation

16:52 EDT Disney reaches deal with Rian Johnson for new 'Star Wars' trilogy - Says has reached deal with director Rian Johnson to develop a new "Star Wars" trilogy, to be released in 2021-2023.

16:49 EDT Disney sees 4-5 feature films for new streaming service - Sees FY18 programming costs up in high single digits. Says developing live action Star Wars series. Sees 4-5 feature films for new streaming service. Says BAMTech "game-changing" acquisition.

16:46 EDT Dynavax announces FDA approval of HEPLISAV-B - Dynavax announced that the U.S. FDA has approved HEPLISAV-B for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is the first new hepatitis B vaccine in the United States in more than 25 years and the only two-dose hepatitis B vaccine for adults. Dynavax expects to commercially launch HEPLISAV-B in the United States in the first quarter of 2018. In preparation for launch, Dynavax has been building commercial infrastructure and optimizing manufacturing processes to meet anticipated demand.

16:45 EDT Disney: FY18 earnings growth to be suppressed somewhat - Says earnings to be suppressed by consolidation of BAMTech, increased share of losses due to Hulu investment.

16:37 EDT McDermott awarded major EPCI contract in the Arabian Gulf - McDermott International announced a major contract award from a Middle East customer for engineering, procurement, construction and installation - EPCI - services offshore in the Arabian Gulf. Work on the contract is expected to begin immediately and will be reflected in McDermott's fourth quarter 2017 backlog. McDermott defines a major contract as between $750M and $1.5B.

16:35 EDT Heron Therapeutics trading resumes

16:33 EDT Hertz up 14% to $22.80 after Q3 results top estimates

16:32 EDT Graham Holdings authorizes stock buyback of up to 500,000 shares - Graham Holdings announced that its board of directors has authorized the company to acquire up to 500,000 shares of its Class B common stock. The company did not announce a ceiling price or time limit for the purchases. This authorization includes the 163,237 shares that remained under the previous authorization.

16:31 EDT Halcon Resources sees FY18 total production 15k-19k Boe/d

16:23 EDT Entercom receives FCC approval for CBS Radio deal - Entercom Communications (ETM) announced receipt of approval from the Federal Communications Commission to complete the proposed tax-free combination with CBS Radio (CBS). The FCC's order concluded that granting its approval to the merger and transfer applications related to the combination of Entercom and CBS Radio will serve the public interest, convenience and necessity. Entercom expects its proposed combination with CBS Radio to close as early as November 17, 2017.

16:15 EDT AllianceBernstein reports preliminary AUM $542B as of October 31

16:14 EDT Talend acquires Restlet, terms not disclosed - Talend announced its acquisition of all outstanding shares of Restlet SAS, a cloud-based API design and testing platform. Restlet uses the cloud to provide powerful API design, documentation, testing and hosting capabilities to developers. Restlet's technology will complement Talend Data Fabric's existing ability to integrate, transform, govern and share enterprise data by making it easier for customers to take an API-first design approach to monetizing and securely sharing information in real-time with clients and business partners.

16:10 EDT Hertz CEO: 'Our operating turnaround plan is showing encouraging progress' - "Our operating turnaround plan, focused on growth through enhanced fleet, service, brands and technology, is showing encouraging progress, evidence that Hertz is on the right strategic path," said Kathryn Marinello, president and CEO of Hertz. "While there is still a lot of work ahead of us, in the third quarter, we benefited from continued improvements in our fleet offering, expansion of our Ultimate Choice program, and a strategic focus on optimizing revenue management. We remain committed to building Hertz's long-term success as a leader in the global rental car market by strengthening the business to drive predictable, sustainable long-term growth."

16:08 EDT SkyWest reports block hours down 3% in October - SkyWest reported 154,479 block hours in October 2017, compared to 159,241 block hours in October 2016, a decrease of 4,762 or 3.0%. The net decrease was consistent with SkyWest's fleet transition plan to improve the mix of aircraft in its fleet by adding new E175 aircraft, while reducing its 50-seat jets. The year-over-year net change was primarily driven by approximately 11,600 additional block hours from its E175 aircraft and a decrease of approximately 16,300 block hours from its other aircraft types. In October 2017, SkyWest's dual class aircraft represented approximately 53% of SkyWest's total block hour production for the month compared to approximately 43% for the month of October 2016. SkyWest had 91,856 departures in October 2017 compared to 95,551 in October 2016, a decrease of 3,695, or 3.9%.

16:08 EDT Immunomedics names Michael Pehl as new CEO - Immunomedics announced that its board has voted to appoint Michael Pehl as President and Chief Executive Officer effective December 7, 2017. He has also been appointed to the board, effective as of the commencement date of Mr. Pehl's employment. Immunomedics also announced that Brendan Delaney has been appointed Chief Commercial Officer at Immunomedics, effective as of November 10, 2017. Michael Garone, current Chief Financial Officer and Interim CEO, will resume his role as CFO.

16:05 EDT Lionsgate reports backlog of $1.3B at September 30 - Lionsgate's backlog, or already contracted future revenue on the licensing of film and television product not yet recorded, was $1.3B at September 30, 2017.

15:43 EDT Tortoise Capital reports 12.8% passive stake in BP Midstream

15:02 EDT Van Berkom & Associates reports 7.01% passive stake in American Renal Associates

13:44 EDT AT&T CEO says 'illogical' to think Time Warner deal doesn't get approved - Randall Stephenson is speaking at the DealBook conference.

13:33 EDT AT&T CEO says been preparing to litigate Time Warner deal from beginning - Randall Stephenson is speaking at the DealBook conference.

13:29 EDT AT&T CEO says never offered to sell Time Warner's CNN unit

13:27 EDT AT&T CEO says no intention of selling Time Warner's CNN - Randall Stephenson is speaking at the DealBook conference.

13:18 EDT Twitter CEO Jack Dorsey says user verification process 'broken' - Twitter CEO Jack Dorsey tweeted, "We should've communicated faster on this (yesterday): our agents have been following our verification policy correctly, but we realized some time ago the system is broken and needs to be reconsidered. And we failed by not doing anything about it. Working now to fix faster." Reference Link

13:00 EDT Macerich jumps 6% after Dan Loeb's Third Point said to take stake - Loeb's fund is pushing for change at Macerich, including a possible sale, according to Bloomberg's report.

12:53 EDT Facebook rolls out program to help U.S. small businesses 'get most' out of web - Facebook introduced Facebook Community Boost, a new program to help U.S. small businesses grow and to equip more people with the digital skills they need to compete in the new economy. Facebook Community Boost will visit 30 US cities in 2018, including Houston, St. Louis, Albuquerque, Des Moines and Greenville, South Carolina. Facebook will work with local organizations to provide digital skills and training for people in need of work, to advise entrepreneurs how to get started and to help existing local businesses and nonprofits get the most out of the internet. Reference Link

12:42 EDT Seattle Genetics announces FDA approval of Adcetris for pcALCL - Seattle Genetics announced that the FDA has approved ADCETRIS for the treatment of adult patients with primary cutaneous anaplastic large cell lymphoma, or pcALCL, and CD30-expressing mycosis fungoides who have received prior systemic therapy. Primary cutaneous ALCL and MF are the most common subtypes of cutaneous T-cell lymphoma. The approval is based on data from the phase 3 ALCANZA trial and two phase 2 investigator-sponsored trials. The phase 3 ALCANZA study was designed to compare ADCETRIS monotherapy administered every three weeks versus physician's choice of representative standard of care options, methotrexate or bexarotene. The trial met its primary endpoint with the ADCETRIS treatment arm demonstrating a highly statistically significant improvement in the rate of objective response lasting at least four months versus the control arm as assessed by an independent review facility. ORR4 was 56.3% in the ADCETRIS arm compared to 12.5% in the control arm. The most common adverse reactions were: anemia, peripheral sensory neuropathy, nausea, diarrhea, fatigue and neutropenia. This is the fourth FDA-approved indication for ADCETRIS, which also has: (1) regular approval for treatment of classical Hodgkin lymphoma patients who fail autologous hematopoietic stem cell transplantation or who fail at least two prior multi-agent chemotherapy regimens and are not auto-HSCT candidates, (2) regular approval for the treatment of patients with cHL at high risk of relapse or progression as post-auto-HSCT consolidation, and (3) accelerated approval for treatment of systemic anaplastic large cell lymphoma patients who fail at least one prior multi-agent chemotherapy regimen. Accelerated approval in the sALCL indication is based on overall response rate, and continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

12:01 EDT Crede CG III reports 9.97% passive stake in TOP Ships

11:27 EDT Bel Fuse trading resumes

11:16 EDT Johnson Controls sees incremental $250M in savings in 2018 - Says needs to improve accelerating organic growth and orders in Buildings segment, expanding gross margins in Buildings, improving free cash flow conversion and consistently delivering on commitments. Says plans to tie compensation incentives to organic sales growth, EBIT growth, FCF conversion. Says increasing sales capacity and execution. Says establishing cash management office to achieve FCF targets. Says will be more selective in capex spending. Says will remain disciplined with capital allocation with a more balanced approach to accretive M&A and share buybacks. Comments taken from Q4 earnings conference call.

11:03 EDT Boeing reports 69 new orders in weekly update - Boeing (BA) reported 69 new orders in the weekly update posted on its website, from Business Jet / VIP Customers for one 737, China Development Bank Fin. for 48 737s and eight 787s, Unidentified Customers for two 777s and five 787s and WestJet for five 737s. In the changes category, reduced 737 orders by 2. Identified Alaska Airlines (ALK) for four 737s, Aviation Capital Group for four 737s, Japan Airlines for four 787s, Qatar Airways for four 777s, and USAF PAR Program for two 747s, previously listed as unidentified. Year to date information: 737 net orders: 46 NG and 396 MAX; 777 net orders: 35 777 and 20 777X.

10:48 EDT Raytheon, Saab team to develop new infantry weapons - Raytheon Company and Swedish aerospace and defense firm Saab will partner to develop new weapons for infantry forces. Initially, the team will upgrade the Carl-Gustaf reloadable shoulder-launched weapon system and explore opportunities to enhance Saab's AT4 disposable weapon system to meet near-term U.S. and international requirements.

10:26 EDT Macy's: To achieve guidance, Q4 comp sales would be down 1.9% to up 1.1% - Says that in order to achieve annual guidance, Q4 comp sales on an owned plus licensed basis would have to be down 1.9% to up 1.1%.

10:18 EDT Macy's CFO sees improvement in comp sales trend in Q4 vs. Q3

10:11 EDT Kohl's 'relatively bullish' on Q4 based on trend of business coming into quarter

10:09 EDT Macy's CEO sees sales lift from digital of 100-150bps in Q4 - On its Q3 earnings conference call, Macy's CEO Jeff Gennette said he expects digital to contribute "strongly" to sales in Q4 and sees a sales lift of about 100-150bps from the increase in penetration of digital sales. Gennette said he expects mobile shopping on Macy's to be "very big" in Q4. Gennette said the early results of the new loyalty program are "promising," adds that Macy's will roll out further enhancements in 2018. CFO Karen Hoguet said the hurricane impact hurt sales in Q3 by about $20M, or 30bps. International tourist sales fell 11.7% in Q3, hurting comps by 50bps. Macy's is up 2.5% to $18.00 in morning trading.

09:59 EDT Anthem issues updated medical policy for Sarepta's Exondys 51 - In a Medical Policy bulletin published November 9, Anthem (ANTM) addressed the antisense oligonucleotide drug, eteplirsen, marketed under the name Exondys 51 by Sarepta Therapeutics (SRPT). Anthem states in the bulletin: "Initiation of therapy with eteplirsen is considered medically necessary for the treatment of Duchenne muscular dystrophy when all of the following criteria are met: Individual has a confirmed diagnosis of Duchenne muscular dystrophy; and Individual must be ambulatory, with or without needing an assistive device, such as a cane or walker; and Individual has a genetic mutation that is amenable to exon 51 skipping." Reference Link

09:35 EDT Gran Tierra agrees to sell Peru business - Gran Tierra announced that it and its indirect wholly-owned subsidiary, Gran Tierra Energy International Holdings, or GTEIH, have entered into a share purchase agreement with PetroTal, and Sterling Resources, pursuant to which GTEIH has agreed to sell all of the issued and outstanding shares of its wholly owned subsidiary, Gran Tierra Energy International Peru Holdings B.V., or GTEIPH, subject to the satisfaction of certain conditions. In connection with the SPA, Sterling and PetroTal have concurrently entered into an arrangement agreement under which they have agreed, subject to certain conditions, that: (a) PetroTal will complete a reverse take-over of Sterling; (b) Sterling and PetroTal will be amalgamated; and (c) the management and board of directors of Sterling will be reconstituted. Subject to the terms of the SPA, the Resulting Issuer has agreed to acquire all of the issued and outstanding shares of GTEIPH from GTEIH as the final step of the Arrangement, in exchange for 187,250,000 common shares of the Resulting Issuer, representing approximately 38% of the issued and outstanding Resulting Issuer Shares, plus or minus a cash-settled working capital adjustment. Gran Tierra will evaluate its investment in the Resulting Issuer from time to time and may, based on such evaluation, market conditions and other circumstances, increase or, subject to applicable escrow periods under the rules of the TSX Venture Exchange, decrease shareholdings as circumstances require through market transactions, private agreements, or otherwise. Closing of the Arrangement and the transactions contemplated by the SPA is subject to a number of conditions precedent, including the completion of a minimum US$25 million equity financing by PetroTal, TSXV approval of, inter alia, the reverse take-over of Sterling and the listing of the Resulting Issuer's shares on the TSXV, certain minimum working capital levels of PetroTal and Sterling and other regulatory and customary conditions. There can be no assurance that the conditions will be met or that the transaction will be completed as proposed or at all.

09:23 EDT LGL Group says engaging investment group on non-binding acquisition proposal - The LGL Group announced that it continues to engage with the investment group that submitted the previously announced non-binding proposal to acquire for cash the assets of its two principal operating subsidiaries, M-tron Industries and Precise Time and Frequency. The investment group has proposed to acquire 100% of the MtronPTF assets on a cash-free, debt-free basis for a total enterprise value of $14M. The investment group advised that its valuation assumes completion of confirmatory financial due diligence, sufficient working capital for current operations, the company is debt and liability free and a transaction can be structured to achieve step up tax goals. The previously appointed special committee of the board will continue to evaluate the non-binding proposal and explore other strategic alternatives as circumstances warrant. No decisions, nor commitments have been made with respect to the non-binding proposal and there can be no assurance that the special committee will authorize the commencement of negotiations with the investment group, and if negotiations commence, there can be no assurance as to whether a definitive agreement will be executed, the terms thereof or that any transaction governed thereby will be consummated, or if consummated, as to the timing thereof. The special committee, in consultation with its legal and financial advisors, continues to carefully review and evaluate the non-binding proposal and as a matter of policy, the Company will not comment on or provide the market with updates as to the status of its discussions with investment group, nor will it comment upon any rumors with regard to the foregoing or make a further announcement regarding the special committee's consideration of any proposal or other expressions of interest until such time, if ever, that it enters into a definitive agreement for a completed transaction or is otherwise required to make an announcement.

09:16 EDT Inseego reports smart city development with Current, powered by GE - Inseego announced integration with Current, powered by GE, including smart city IoT sensor platform installation in San Diego. This large scale deployment involves 3,200 intelligent CityIQ sensor nodes that will help optimize traffic and parking, plus enhance public safety, environmental awareness and overall livability for the city of San Diego, CA.

09:15 EDT Charles River says sees FY17 free cash flow $265M-$275M - Expects the consolidated portfolio will deliver high-single-digit organic revenue growth, EPS at a higher rate than revenue, and strong free cash flow. Says Maryland closure will generate modest cost savings in 2018. Expects to generate at least $3M in annualized savings, beginning in 2019. Continues to expect unallocated corporate expenses will be approximately 7% of total revenue. Expects FY17 GAAP tax rate to be in a range of 31.0%-31.5%, non-GAAP tax rate in a range of 27.0%-27.5%. Expects FY17 free cash flow $265M-$275M, capex of about $75M. Expects to favor debt repayment over stock repurchases in Q4 and throughout 2018. Expects low-single-digit organic revenue growth in RMS, high-single-digit organic growth in DSA, continues to expect organic revenue growth of 10% or higher in the Manufacturing Support segment.

09:12 EDT CVS Health: Naloxone now available without prescription in several new states - CVS Health (CVS) announced that the opioid overdose-reversal medication naloxone is now available without an individual prescription at the 20 CVS Pharmacy locations in Delaware, including those located inside Target (TGT) stores. CVS Pharmacists will be able to dispense naloxone to patients without an individual prescription under a statewide standing order protocol. CVS Health also announced that naloxone is now available without an individual prescription at all of the nearly 300 CVS Pharmacy locations in Michigan, and 77 CVS Pharmacy locations in Oklahoma.

09:09 EDT Kohl's CEO says 'optimistc' on women's apparel turning positive - Says "less optimistic" on accessories turning positive.

09:08 EDT Textainer sees revenue increasing on current conditions - The company said, "We are very optimistic about the outlook for both Textainer and our industry. The manufacturers are full through November. Production during the winter will be constrained due to the difficulty in applying water-born paint in cold temperatures. Steel prices may strengthen due in part to enforcement of pollution regulations in China leading to the closure of some steel producers. For these reasons, we do not expect new container prices to decline over the coming quarters. The inventory of new containers at factories is approximately 400,000 TEU which we consider reasonable given the current outlook for demand and production. With utilization at such high levels, worldwide depot inventory is also very low. We expect rental rates to remain around current levels given the disciplined ordering of new containers by lessors and shipping lines and the constraints on new container production. Sales prices should remain around today's levels because the quantity of containers being put to sale is limited due to high utilization at lessors and shipping lines. Over the coming years, we will benefit not just from the projected continued strong growth in container trade but also from revenue upside from lease repricing. Leases maturing in 2018 have average rates of 56c per CEU per day and this figure declines to 36c per CEU per day by 2021. These rates are well below current new and depot container rental rates. If current market conditions continue, as these leases reprice any increase in rental revenue will flow straight to our bottom line."

09:06 EDT E.W. Scripps names Lisa Knutson as CFO - The E.W. Scripps Company has appointed its chief strategy officer, Lisa Knutson, as executive vice president and CFO after a four-month, nationwide search. Knutson has been serving as interim CFO since the departure of Tim Wesolowski in early October. Prior to coming to Scripps in 2005, she had worked most of her career at Fifth Third Bank and at Arthur Anderson.

09:04 EDT Nielsen incorporating Comcast's set-top box data into local TV measurement - Nielsen (NLSN) announced an agreement to use Comcast's (CMCSA) set-top box data in its local television measurement service. With this agreement, Comcast becomes the fourth major cable or satellite provider whose non-personally identifiable TV viewing data is being integrated with Nielsen's comprehensive panel data.

09:04 EDT GoDaddy announces two new integrations with Square - GoDaddy (GDDY) announced two new integrations with Square (SQ) that help small businesses thrive with online and offline selling and payment capabilities. Increasingly, businesses need to operate both in person and online to succeed. By collaborating with Square, GoDaddy is making this an easy reality for tens of millions of people building small businesses. As a first step in the partnership, GoDaddy has integrated Square payments for e-commerce product sales and online appointment booking in GoCentral, GoDaddy's mobile-optimized website builder. Integrating GoCentral Online Store and Square online payments enables small businesses to easily sell their products and services online and in person through a single Square account and GoDaddy website. The second integration provides service-based businesses, such as personal trainers, hair stylists and photographers, the ability to book client appointments online, sync calendars using GoCentral, and get paid using Square. Payment transactions can be processed online, in-person or both without switching accounts.

09:03 EDT Amazon sells Alexa-enabled devices in Whole Food locations - Whole Foods Market and Amazon announced that customers can now shop for Amazon devices such as the all-new Amazon Echo, Echo Dot, Fire TV, Kindle e-readers, Fire tablets and more at over 100 Whole Foods Market stores. In addition, Amazon Pop-Up stores will open at Whole Foods Market stores in Chicago, Illinois and Rochester Hills, Michigan on Nov. 13; Davie, Florida and Pasadena, California on Nov. 14; and the new Union Station store in Denver, Colorado on Nov. 15. Just in time for holiday shopping and entertaining, Whole Foods Market customers will be able to try out Amazon devices and learn about services like Prime and unique content on Prime Video at the staffed Amazon Pop-Up stores. In addition to getting to know Alexa and test-driving some of Amazon's best-selling devices, 'tis the season for Whole Foods Market customers to get a head start on their holiday gifting by taking advantage of upcoming Black Friday deals. Starting the week leading up to Black Friday, Amazon is offering a variety of deals including $20 off the Echo Dot, $20 off the all-new Amazon Echo, $30 off the new Echo Plus, $30 off Kindle Paperwhite, $20 off the new Amazon Cloud Cam, $20 off Fire 7 tablet and $30 off Fire HD 8 tablet.

09:02 EDT AmerisourceBergen increases dividend 4% to 38c per share - The Board of Directors of AmerisourceBergen increased the company's quarterly dividend rate 4% to 38c per common share from 36.5c per common share. The quarterly dividend of 38c per common share will be payable December 4, 2017, to stockholders of record at the close of business on November 20, 2017.

08:59 EDT Kohl's CEO says Vera Wang business 'great'

08:55 EDT Anthera completes recruitment in Phase 3 RESULT clinical study of Sollpura - Anthera Pharmaceuticals announced that patient recruitment is now complete for the Phase 3 RESULT clinical study of Sollpura for the treatment of Exocrine Pancreatic Insufficiency caused by cystic fibrosis. Topline data is expected in Q1 2018.

08:51 EDT Charles River says will continue to invest in strategic acquisitions - Expanding production capacity in China with site in Shanghai, construction completed and expects to begin shipping in early 2018. Plans to close our RM production facility in Maryland and consolidate production in other facilities before the end of 2018. Will continue to provide the same research model strains to clients. Expects closure of Maryland site to generate savings in 2019. Will continue to invest in RM business automation. Expects to report SA revenue growth in high-single digits for FY17. Says optimistic that ability to provide a total microbial testing solution for clients will be a driver of goal for Microbial Solutions to continue to deliver low-double-digit organic revenue growth for the foreseeable future. Expects further investment in Biologics and continues to hire staff. Says will continue to invest in facilities, increase staff. Comments taken from Q3 earnings conference call.

08:42 EDT Piper Jaffray trading resumes

08:37 EDT Qumu closed twelve new enterprise video clients in Q3 - Qumu (QUMU) has announced the closing of twelve new enterprise video clients in the third quarter of 2017. These wins mark one of the company's most positive sales quarters in nearly two years, and represent both emerging and Global 2000 companies located in the United States, Asia-Pacific and EMEA. Qumu's recent wins span a variety of use cases, serviced by on-premise, cloud-based and hybrid solutions. A few of the company's more notable new customers include food manufacturer Campbell's (CPB) employee-owned grocery chain Hy-Vee, a leading French banking and financial services company, and Japanese pharmaceutical companies Sumitomo Dainippon Pharma and Mitsubishi Tanabe Pharma-a subsidiary of Mitsubishi Chemical Holdings Corporation. During the third quarter of 2017, Qumu also closed three major deals in the financial industry, including an on-premise implementation with one of the largest commercial banking networks in the southeastern United States. In addition, Qumu signed agreements with both CIT Group (CIT) and The D.E. Shaw Group.

08:35 EDT B Riley Financial trading resumes

08:34 EDT FirstEnergy Ohio utilities' electric security plan ESP-IV auction - CRA International (CRAI) announced that an auction process will be conducted for FirstEnergy (FE) Ohio utilities to procure full requirements service for their Standard Service Offer customers. The auction process will lead up to the auction scheduled for January 29, 2018. The bidding process will use a descending-price clock auction format. The auction will be managed by Auction Manager CRA International. The auction is being conducted pursuant to FirstEnergy's Ohio Electric Security Plan as approved by the Public Utilities Commission of Ohio. This is the sixth auction in the series of ESP-IV auctions. The Information Session for prospective bidders for the January auction is scheduled for Wednesday, November 15, 2017. Instructions on how to join the Webcast session are available on the Auction Information Website at www.firstenergycbp.com. Part 1 Applications from prospective bidders will be accepted starting November 15 and are due no later than December 6. For successful Part 1 applicants, the submission window for the Part 2 Application process will be December 13 through January 8. The products in the January 29 auction are a 24-month contract and a 36-month contract.

08:28 EDT B. Riley Financial to acquire magicJack for $8.71 per share - B. Riley Financial (RILY) and magicJack VocalTec (CALL) have signed a definitive merger agreement, pursuant to which B. Riley will acquire magicJack for $8.71 per share, representing a 23% premium over magicJack's 90-day average stock price and approximately $143M in aggregate merger consideration. It is anticipated that magicJack will be held by B. Riley's subsidiary B. Riley Principal Investments, LLC, the entity that currently owns United Online, Inc., a complementary telecommunications company. B. Riley expects to finance the transaction using cash on hand and debt financing. The transaction is expected to close in the first half of 2018.

08:25 EDT IsoRay launches Phase II Multicenter Clinical Trial with Cesium-131 - IsoRay announced the launch of a Phase II, Multicenter Clinical Trial with Cesium-131 Adjuvant Radiation for Retroperitoneal Sarcoma Delivery System (CARDS Trial) by the University of Louisville, Division of Surgical Oncology, Louisville, KY. The Division of Surgical Oncology at the University of Louisville has a long-standing commitment to excellence in research, education, and patient care. As one of the largest Divisions of Surgical Oncology in the U.S., and one of the top training programs as well, the faculty members have broad clinical and research interests. The principal investigator for the study is Charles R. Scoggins, M.D., a professor of Surgical Oncology. Among his co-investigators are other surgical oncologists as well as Robert C.G. Martin II MD, PhD, Prejesh Philips MD, and Michael Egger MD, MS. The primary objective of the study is to compare the efficacy of Cesium-131 mesh placement on overall and recurrence free survival of patients who underwent resection for retroperitoneal sarcoma to historical series where resection is the sole treatment. The study is expected to begin enrolling 12 patients with retroperitoneal sarcoma who will have the Cesium-131 implant placed in the abdominal cavity at the time the sarcoma is surgically removed. The Cesium-131 implant delivers a high dose of radiation very close to where tumor cells may be left behind after a surgery intended to remove all of these cells has been completed. Due to the very compact and targeted nature of the dose, other critical structures in the retroperitoneum are not expected to be exposed to these high levels of radiation, reducing the possibility of radiation injury to uninvolved anatomy.

08:15 EDT Internap signs multi-year colocation deal with Luxcore - Internap announced a multi-year agreement for colocation services in seven global locations. Luxcore is strategically partnering with INAP in a flagship venture to deliver the industry's first all-optical wavelength switching, routing and transport capabilities of the second generation LambdaRouter. When combined with INAP's global reach, unprecedented Tier 1 interconnectivity and dark fiber, Luxcore will introduce the "Optical Internet" providing significant new revenue opportunities for both INAP and Luxcore.

08:12 EDT Alkermes calls for review of data supporting use of opioid dependence treatments - Alkermes is calling for a formal review by the National Institutes of Health of data related to all FDA-approved medication-assisted treatment options for opioid dependence. The goal of this review should be to establish a shared national understanding of the characteristics of these medicines and the scientific and medical evidence supporting their use. This review should evaluate the efficacy and safety of these treatment options, the specific patient populations most likely to benefit from them, as well as the data relating to overdose prevention, diversion, illicit use, craving, patient satisfaction and other important aspects of recovery. With a complete understanding of the body of evidence supporting MAT, treatment providers in the community will be better equipped to make data-driven treatment decisions customized to individual patient needs. Alkermes proposes a public meeting, led by NIH/NIDA, which includes presentation and review of medical and scientific data pertaining to FDA-approved medications for opioid dependence, including expert testimony from representatives of NIH, NIDA, the CDC, the FDA, the Surgeon General, and the National Institute of Corrections, and unbiased and unconflicted data-driven patient and professional associations, including the American Academy of Addiction Psychiatry. There are abundant data on these medicines, and despite this, myths and misperceptions are perpetuated and, as a result, most patients are not gaining access to MAT.

08:09 EDT DineEquity sees FY17 adjusted free cash flow $60M-$70M

08:08 EDT DineEquity revises FY17 outlook - Revised expectations for Applebee's domestic system-wide comparable same-restaurant sales performance to range between negative 5.5% and negative 6.5%. This compares to previous expectations of between negative 6.0% and negative 8.0%. Reiterates expectations for IHOP's domestic system-wide comparable same-restaurant sales performance to range between negative 1.0% and negative 3.0%. Reiterates expectations for Applebee's franchisees to develop between 20 and 30 new restaurants globally, the majority of which are expected to be international openings. Reiterates expectations for Applebee's closures to range between approximately 105 and 135 restaurants. Reiterates expectations for IHOP franchisees and its area licensee to develop between 80 and 95 restaurants globally, the majority of which are expected to be domestic openings. Revised expectations for IHOP closures to range between 25 and 30 restaurants. This compares to previous expectations of between 20 and 25 restaurants. Revised expectations for Franchise segment profit to be between $297 million and $303 million. This compares to previous expectations of between $302 million and $314 million. This downward revision is primarily due to additional expected reserves related to the collectability of Applebee's royalties. Reiterates expectations for the Rental and Financing segments to generate approximately $38 million in combined profit. Reiterates expectations for general and administrative expenses to range between $166 million and $172 million, including non-cash stock-based compensation expense and depreciation of approximately $22 million. Reiterates expectations for interest expense to be approximately $62 million. Approximately $3 million is projected to be non-cash interest expense. Reiterates expectations for weighted average diluted shares outstanding to be approximately 18 million shares. Reiterates expectation for the income tax rate to be approximately 40%. Revised expectations for cash flows provided by operating activities to range between $64 million and $74 million. This compares to previous expectations of between $80 million and $90 million. The decline is primarily due to the timing of fourth quarter 2017 marketing spend and projections for lower Franchise segment profit as discussed above. Reiterates expectations for capital expenditures to be approximately $14 million. Revised expectations for adjusted free cash flow (See "Non-GAAP Financial Measures" below) to range between $60 million and $70 million. This compares to previous expectations of between $76 million and $86 million.

08:05 EDT BIOLASE announces commencement of rights offering - BIOLASE announced that it has commenced its previously announced rights offering to holders of shares of its common stock. Under the terms of the rights offering, the company distributed to its shareholders as of 5:00 p.m., Eastern Time, on November 8, 2017, the record date, 0.346 subscription rights exercisable for each share of the Company's common stock owned. Each whole subscription right entitles the holder to purchase one share of the Company's common stock at a subscription price equal to $0.456 per share. The subscription period expires at 5:00 p.m., Eastern Time, on November 29, 2017, unless extended. The rights offering also includes an over-subscription privilege, which permits each rights holder that exercises the basic subscription privilege in full the option to purchase additional shares of common stock that remain unsubscribed at the expiration of the offering, subject to allotment. Certain affiliates of Larry Feinberg and certain affiliates of Jack Schuler have each agreed with the Company to exercise their respective basic subscription rights and any available over-subscription privilege pursuant to the rights offering in an amount not less than $3,000,000 and $3,000,000, respectively. The purpose of the rights offering is to raise equity capital in a cost-effective manner that gives all of the Company's existing stockholders the opportunity to participate on a pro rata basis. The net proceeds of the offering will be used for the Company's general working capital needs. If the rights offering is successful, the Company expects to receive gross proceeds of approximately $12,000,000 before expenses.

08:01 EDT Macy's backs sales, earnings guidance for FY

08:00 EDT MagicJack trading halted, news pending

07:47 EDT HP Enterprise increases dividend approximately 15% to 7.5c per share - Hewlett Packard Enterprise announced that the Hewlett Packard Enterprise Board of Directors has declared a regular cash dividend of 7.5c per share on the company's common stock. This is an increase of approximately 15% from the prior dividend. This dividend, the first in Hewlett Packard Enterprise's fiscal year 2018, is payable on or about January 3, 2018, to stockholders of record as of the close of business on December 13, 2017.

07:39 EDT Idera Pharm presents translational, clinical data update from IMO-2125 program - Idera Pharmaceuticals announced updated translational data from the ongoing Phase 1/2 study of intratumoral IMO-2125 in combination with ipilimumab for the treatment of anti-PD-1 refractory metastatic melanoma. These data will be presented at 4:45 P.M. E.T. on Saturday, November 11th in Maryland Ballroom A at the Gaylord National Hotel & Conference Center as part of Concurrent Session 207: Clinical Trials: Novel Combinations at the 2017 Society for Immunotherapy of Cancer Annual Meeting being held in National Harbor, MD. In the oral presentation entitled, "TLR9 agonist harnesses innate immunity to drive tumor-infiltrating T-cell expansion in distant lesions in a Phase 1/2 study of intratumoral IMO-2125 plus ipilimumab in anti-PD-1 refractory melanoma patients," Cara Haymaker, Ph.D., from The University of Texas, MD Anderson Cancer Center, will present an update of the essential translational findings from the Ongoing Phase 1/2 trial of IMO-2125. Adults with anti-PD-1 refractory, unresectable stage III/IV melanoma were enrolled. IMO-2125, escalating from 4 - 32 mg is administered under image guidance, intratumorally on weeks 1, 2, 3, 5, 8, and 11 with standard ipilimumab. Biopsies were obtained in both the injected and distant tumor at baseline, 1 day and 8 weeks post injection. Immune analyses included phenotypic, activation, and functional characterization of DC subsets and T cells. T-cell repertoire diversity was evaluated by high-throughput CDR3 sequencing and changes in gene expression signatures were assessed by nanoString. Key Highlights to be Presented Include: IMO-2125 induces a strong Type 1 interferon gene signature, macrophage influx and robust dendritic cell maturation post-injection; Combination therapy induces CD8+ T-cell proliferation and activation that is preferential to the tumor; The hallmark of observed tumor shrinkage appears to be the presence of Ki67+ CD8+ T-cell effector cells in the distant/un-injected tumor.

07:38 EDT BrainStorms NurOwn featured in peer-reviewed publication - BrainStorm announced that a study profiling NurOwn's unique miRNA signature has been published online in the peer-reviewed journal Stem Cell Research & Therapy. The publication is authored by members of Brainstorm's scientific team. The publication shows that NurOwn cells have both an enhanced secretion of NTFs as well as a distinct miRNA expression profile that distinguishes them from their MSCs of origin. The study shows that BrainStorm's proprietary differentiation process modulates miRNA expression, leading to a unique miRNA signature.

07:35 EDT Johnson Controls appoints John Donofrio as EVP, general counsel - Johnson Controls announced it has named John Donofrio as executive vice president and general counsel effective Nov. 15, 2017. Donofrio, who will also serve as a corporate officer, succeeds Judy Reinsdorf, who served in the general counsel role since Sept. 2, 2016, following the merger of Johnson Controls and Tyco.

07:31 EDT Alliqua engages Cowen to assist in evaluating potential strategic alternatives - Alliqua BioMedical announced that it has engaged Cowen as its independent financial advisor to assist the company in evaluating potential strategic alternatives. No assurances can be made as to whether a strategic transaction will be recommended by the board, and the company does not intend to discuss developments with respect to the evaluation process unless a transaction is approved or disclosure becomes appropriate.

07:22 EDT Cenveo sells office products business to LSC Communications - Cenveo's (CVO) wholly-owned subsidiary, Cenveo Corporation, has sold its office products envelope business commonly known as Quality Park Products, to LSC Communications (LKSD). The sale involves two facilities located in the U.S.

07:20 EDT Oragenics trading resumes

07:18 EDT Party City announces $100M share repurchase program

07:12 EDT Alliance Resource unit reports distribution partnership with NLT - Matrix Design Group, a unit of Alliance Resource Partners, announced a distribution partnership agreement with Northern Light Technologies for distribution and service of the N-Connex system throughout the United States and Africa. N-Connex is an award-winning networking system designed specifically for harsh environments, integrating voice and high-speed data communications, asset and personnel tracking, control and automation, video surveillance, condition monitoring and other solutions into a single modular, Wi-Fi and Ethernet based platform.

07:11 EDT Travelers sees Q4 catastrophe losses from CA wildfires $525M-$675M pretax - As previously announced, The Travelers Companies will host an Investor Day on Monday, Nov. 13. The company's senior executive team will update investors on the business and discuss certain strategic initiatives. In advance of the conference, the company today announced that it estimates fourth quarter catastrophe losses related to the recent California wildfires, including estimated recoveries from reinsurance, will be in the range of $525M-$675M pre-tax -- $340M-$440M after-tax. The company's estimates reflect, among other factors, the high average replacement value of homes in the affected areas and a high incidence of total losses, which also include contents, other structures and additional living expenses. The company's estimates also reflect losses from its commercial businesses, including its Agribusiness unit. "The toll from one of the worst wildfire events in U.S. history is devastating," said Alan Schnitzer, Chairman and CEO. "Lives were tragically lost, property and personal possessions were destroyed and entire communities are now forced to start over. Our claim professionals are on the ground, and we'll work tirelessly with our customers to help them and their communities recover as quickly as possible." The company also announced that based on its strong capital position and its expected results for the full year, it intends to resume repurchases of its common shares consistent with its long-standing capital management strategy of returning excess capital to shareholders. The company had previously suspended its common share repurchase activity as it assessed catastrophe losses from recent hurricanes and the wildfires.

07:08 EDT Osisko acquires Gold Stream on Aquila Back Forty project - Osisko Gold Royalties announced that its wholly-owned subsidiary, Osisko Bermuda Limited, or OBL, has agreed to acquire a gold stream with reference to the future gold produced from the Back Forty property located in Michigan from Aquila Resources. OBL will make a staged upfront cash deposit to Aquila of up to $55 million for the Gold Stream, and will make ongoing payments equal to 30% of the spot price of gold, to a maximum of $600 per ounce. Back Forty is a development-stage project located in Michigan's Upper Peninsula. The deposit is a zinc and gold-rich volcanogenic massive sulfide, or VMS, deposit located along the mineral-rich Penokean Volcanic Belt. Over the past 10 years, Aquila and various joint venture partners have invested more than $75 million exploring and advancing Back Forty. Aquila completed a preliminary economic assessment for the Project in 2014 that demonstrated positive economics, and estimated total payable gold production of 532,000 ounces, including 145,000 ounces in the first year. Aquila is currently completing a feasibility study for the Project, which is expected to be released in early 2018. In addition to the Gold Stream, OBL has agreed to purchase units in the amount of US$10 million as part of a concurrent private placement with Aquila.

07:01 EDT SemGroup to sell interest in Glass Mountain Pipeline for $300M to BlackRock - SemGroup (SEMG) has reached an agreement to sell its 50% interest in Glass Mountain Pipeline to an affiliate of BlackRock's (BLK) Global Energy and Power Infrastructure Fund in partnership with Navigator Energy Services for $300M. Glass Mountain Pipeline is a joint venture owned equally between SemGroup and NGL Energy Partners (NGL). SemGroup subsidiary Rose Rock Midstream serves as the pipeline operator. Glass Mountain Pipeline owns the Glass Mountain Pipeline system. The current pipeline is 215-miles long and delivers crude oil from the Mississippi Lime and Granite Wash plays to Cushing, Okla. Construction on a 44-mile pipeline extension of the pipeline is expected to be complete by year-end 2017 and operational by 1Q18. The Glass Mountain sale is expected to close in Q4, subject to the receipt of certain governmental approvals and the satisfaction of other customary closing conditions.

06:55 EDT Office Depot sees FY17 CapEx approximately $125M - Office Depot continues to anticipate free cash flow from continuing operations to be more than $300M in 2017. The company anticipates a non-GAAP effective tax rate of approximately 41% in fiscal 2017, dependent on the mix and timing of income. As the company continues to utilize available tax operating loss carry forwards and credits, the estimated cash tax rate is expected to be approximately 15%.

06:54 EDT Office Depot: Cost saving initiatives to deliver $250M in savings by 2018-end - Office Depot's cost saving initiatives that were part of the Comprehensive Business Review are expected to deliver over $250 million in annual benefits by the end of 2018, with about two-thirds of the total benefits anticipated to be realized by the end of 2017. The company continues to estimate it will incur approximately $125 million in costs to implement the Comprehensive Business Review cost saving programs, of which $90 million has been incurred since inception through the third quarter of 2017. Furthermore, the company expects to realize an additional $40 million of expected synergies from the CompuCom acquisition over the next two years. As recently announced on October 3, 2017, Office Depot now expects adjusted operating income to be between $400 million and $425 million in fiscal 2017. The reduction reflects lower sales and traffic during this year's Back-to-School season, higher supply chain costs related to planned consolidations, hurricane impacts and continued investments related to the company's new direction to become a services-driven company.

06:43 EDT lululemon announces Creative Director Lee Holman resigns for personal reasons - lululemon announced that Lee Holman, Executive Vice President and Creative Director, has resigned for personal reasons. Holman will remain with the company until December 31.

06:39 EDT D.R. Horton maintains goal of growing revenue at double-digit annual pace - The company says: "We remain focused on growing our revenues and pre-tax profits at a double-digit annual pace, while continuing to generate positive annual cash flows and improved returns. With 26,200 homes in inventory at the end of the year, 249,000 lots owned and controlled, and positive sales trends in October, we are excited and well-positioned for continued strong performance in 2018."

06:34 EDT Coty CEO: Results are likely to be a bit uneven going forward - Commenting on Coty's performance, Camillo Pane, Coty CEO said: "Q1 was a much better quarter. We saw strong growth in Luxury, continued positive momentum in Professional and a reduced net revenue decline in the Consumer Beauty division. While results are likely to be a bit uneven from quarter to quarter going forward, the improving revenue trend gives me confidence that the growth strategy I outlined earlier this year is moving Coty gradually onto a path of full recovery. We also delivered significant improvement in profits, driven by better gross margin performance and strong financial discipline on the cost structure. I am pleased to announce that, as of September 1, we have exited our third and final TSA with P&G for the ALMEA region and now have control of processes, systems and data across the new Coty. We are also satisfied with the contributions from our other strategic acquisitions, Hypermarcas, ghd and Younique and continue to strengthen our overall portfolio through our strategic partnership with Burberry, an iconic brand that is an exciting addition to our portfolio. We believe we are uniquely positioned to develop and grow this luxury brand to its full potential. Looking ahead to the remainder of fiscal 2018, we expect to continue to deliver on our announced synergies, finalize the streamlining of our brand portfolio and relaunch several of our key brands. With these programs, we aim to deliver improved net revenue growth trends for the remainder of the year, with an organic second half top line roughly comparable to prior year, as well as healthy margin improvement over the balance of the year. I am highly confident that all of our efforts will lead to Coty becoming a new global leader and challenger in beauty."

06:31 EDT Materialise reports Q3 EPS (4c), consensus (1c) - Reports Q3 revenue $38.14M, consensus $38.55M.

06:09 EDT Foresight Energy sees FY17 sales volume 21.3-21.7 million tons - Sees adjusted EBITDA $290M-$300M, CapEx $72M-$77M.

06:05 EDT Sage Therapeutics' brexanolone achieves primary endpoint in Phase 3 trial - Sage Therapeutics announced positive top-line results from two Phase 3 clinical trials with its proprietary i.v. formulation of brexanolone; Study 202B in severe postpartum depression and Study 202C in moderate PPD. Brexanolone achieved the primary endpoint in both trials, a mean reduction from baseline in the Hamilton Rating Scale for Depression total score compared to placebo at 60 hours. Patients treated with brexanolone demonstrated mean reductions from baseline in HAM-D total scores of 14 to 20 points at 60 hours maintained to 30 days in both trials. Brexanolone was generally well tolerated and showed a similar safety profile as seen in earlier studies. Sage believes these data will be sufficient to support submissions of regulatory applications seeking approval of brexanolone for PPD. Sage plans to file a New Drug Application with the FDA in 2018.

06:01 EDT Microsoft testing 'Near Share' features for Windows 10 - Microsoft (MSFT) is introducing its own version of Apple's (AAPL) AirDrop feature in Windows 10. The software giant has started testing its "Near Share" feature of Windows 10 in the latest Insider build. Like AirDrop, Near Share will let Windows 10 PCs share documents or photos to PCs nearby via Bluetooth. Microsoft explains, "Say you're in a meeting with your boss and need to quickly send them the report you're looking at on your screen? Or you and a sibling are hanging out on the couch using your laptops, and you want to send him a screenshot of your latest Minecraft creation? You can now wirelessly share files and URLs to nearby PCs using the new Near Share feature." Reference Link

05:48 EDT Boeing, CASC sign agreement for 300 airplanes - Boeing and China Aviation Suppliers Holding Company, or CASC, signed an agreement for 300 airplanes during a ceremony in Beijing. It was part of the United States trade mission to China, and was signed by Kevin McAllister, Boeing Commercial Airplanes president and CEO, in the presence of US President Donald Trump and China President Xi Jinping. The agreement includes orders and commitments for 300 Boeing single-aisle and twin-aisle airplanes. The airplanes are valued at more than $37B at list prices.

05:40 EDT Qualcomm signs MoU with Xiaomi, OPPO and vivo - Qualcomm Technologies, a subsidiary of Qualcomm, announced that it has signed three non-binding memoranda of understanding, or MoU, wherein Xiaomi Communications, Guangdong OPPO Mobile Telecommunications and vivo Communication Technology each expresses a nonbinding interest in the purchase of components with an aggregate value of no less than $12B over the next three years. The MoUs were signed at a ceremony at the Great Hall of the People in Beijing led by President of the People's Republic of China Xi Jinping and President of the United States Donald Trump. Qualcomm CEO Steve Mollenkopf was part of President Trump's Department of Commerce Trade Delegation to China, that included executives of leading American companies.